Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-24 | New | $3,474,946 | $3,474,946 | Equity Only | 06b | SEC link |
| 2022-12-16 | New | $4,379,992 | $4,379,992 | Equity Only | 06b | SEC link |
| 2021-10-18 | New | $10,785,072 | $10,785,072 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Kwangmin Son | Director, Executive |
| Roman Stocker | Director, Executive |